Filip Vrbacký

Cervical Microbiota in Women with Preterm Prelabor Rupture of Membranes

Marián Kacerovský, Filip Vrbacký, Radka Kutová et al. · PLoS ONE · 2015 · 68 citations · Full text

IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?

Lucie Petrová, Filip Vrbacký, Miriam Lánská et al. · Clinical Biochemistry · 2018 · 34 citations

Hematological Malignancy, Oncology, Medicine +11

Genotypes of SLC22A4 and SLC22A5 regulatory loci are predictive of the response of chronic myeloid leukemia patients to imatinib treatment

Monika Jaruskova, Nikola Čuřík, Rajna Hercog et al. · Journal of Experimental & Clinical Cancer Research · 2017 · 25 citations · Full text

Venous thromboembolism in patients with chronic lymphocytic leukemia

Martin Šimkovič, Pavel Vodárek, Monika Motyčková et al. · Thrombosis Research · 2015 · 23 citations

Thrombosis, Venous Disease, Venous Thrombosis +4

<i>COBLL1</i>,<i>LPL</i>and<i>ZAP70</i>expression defines prognostic subgroups of chronic lymphocytic leukemia patients with high accuracy and correlates with<i>IGHV</i>mutational status

Hana Plešingerová, Zuzana Librova, Karla Plevová et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2016 · 21 citations